Abstract
Cardiac resynchronization therapy (CRT) devices have the highest risk for reoperation among cardiac implantable electronic devices, primarily due to dislodgement resulting in increases in left ventricular (LV) lead capture threshold. It is unclear whether LV lead repositioning for a moderately increased capture threshold results in improved outcomes over long-term follow up.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
